Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 18;24(1):1441.
doi: 10.1186/s12909-024-06393-z.

Interventions to improve pharmacists' competency in chronic disease management: a systematic review of randomized controlled trials

Farida Rendrayani  1 , Auliasari M Utami  1 , Widya N Insani  1 , Falerina Puspita  1 , Sofa D Alfian  1   2   3 , Thang Nguyen  4 , Irma M Puspitasari  5   6
Affiliations

Interventions to improve pharmacists' competency in chronic disease management: a systematic review of randomized controlled trials

Farida Rendrayani et al. BMC Med Educ. .

Abstract

Introduction: Effective chronic disease management (CDM) is vital for addressing chronic disease challenges. Given the importance of ensuring pharmacists' competence in CDM, interventions targeting knowledge, skills, and attitudes are essential. Therefore, a comprehensive and up-to-date study is needed to analyze these interventions' effect and potential development. Categorizing the interventions based on the Effective Practice and Organization of Care (EPOC) taxonomy is essential for better informing policymakers. The objectives of this systematic review were to identify interventions to improve pharmacists' competency in chronic disease management based on the EPOC taxonomy and summarize their effectiveness.

Methods: Following methods in the Cochrane Handbook, a systematic search was conducted up to April 2024 on MEDLINE and Scopus. The inclusion criteria were an intervention study with a randomized controlled trial (RCT) design published in English, targeting pharmacists, and measuring knowledge, skills, and attitudes in aspects of CDM. The risk of bias was assessed using Cochrane's RoB 2 tool for either randomized or cluster-randomized trials. Findings are reported narratively and align with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.

Results: We included 11 RCT studies that focused on various aspects of CDM among community and hospital pharmacists. Implementation strategies and combined implementation strategies-delivery arrangements interventions were identified. Six implementation strategies interventions consistently yielded effective results, with scores ranging from 0.99 to 9.17 (p < 0.05). However, the other two implementation strategies interventions reported mixed results, with no significant improvements in knowledge or skills. Two implementation strategies-delivery arrangements interventions showed improvements, with score differences ranging from 4.5% (95% CI: 1.6%-7.4%) to 30% (95% CI: 29%-40%). Conversely, one implementation strategies-delivery arrangements intervention showed no significant improvement. The risk of bias assessment revealed varying levels of bias across the studies.

Conclusions: Implementation strategies and combined implementation strategies-delivery arrangements interventions improved pharmacists' competency in CDM. Most interventions consistently resulted in significant improvements in pharmacists' knowledge, skills, and attitudes. These findings underscore the potential of tailored, competency-based interventions to improve pharmacist competencies in CDM. Policymakers can use these insights to create guidelines and policies that promote ongoing professional development for pharmacists.

Keywords: Chronic disease; Competency; Disease management; Intervention; Pharmacists.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interest: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The study selection process
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Reynolds R, Dennis S, Hasan I, Slewa J, Chen W, Tian D, et al. A systematic review of chronic disease management interventions in primary care. BMC Fam Pract. 2018;19:1–13. 10.1186/s12875-017-0692-3. - PMC - PubMed
    1. Van Wilder L, Pype P, Mertens F, Rammant E, Clays E, Devleesschauwer B, et al. Living with a chronic disease: insights from patients with a low socioeconomic status. BMC Fam Pract. 2021;22:1–11. 10.1186/s12875-021-01578-7. - PMC - PubMed
    1. WHO. Noncommunicable diseases. World Health Organization 2022. https://www.who.int/health-topics/noncommunicable-diseases#tab=tab_1. Accessed 23 Dec 2022.
    1. Grover A, Joshi A. An overview of chronic disease models: a systematic literature review. Glob J Health Sci. 2015;7:210–27. 10.5539/gjhs.v7n2p210. - PMC - PubMed
    1. Bloom DE, Chen S, Kuhn M, McGovern ME, Oxley L, Prettner K. The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea. The Journal of the Economics of Ageing. 2020;17:1–29. 10.1016/j.jeoa.2018.09.002.

Publication types

LinkOut - more resources